REWARDS Premier Taxus-Liberte vs Xience V

Completed

Conditions studied: Coronary Artery Disease

In brief

Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received either the Taxus Liberte or XIENCE V drug eluting stent.

Key facts

Study ID

NCT02256527

Run by

Medstar Health Research Institute

People needed

917

Starts

2014-09-01

Expected to finish

2015-10-01

Last updated by the study team

2016-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years of age or older
• Underwent PCI with Promus Premier (alone) DES

You may not qualify if…

• Underwent PCI with a non-Promus Premier DES during the same index procedure
• Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel, prasugrel, or ticagrelor)

Where it is running

• Washington Hospital Center — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.